Learn

The prevalence of obesity among adults has nearly tripled worldwide since 1975 to more than 650 million in 2016, including 31% of adults in Australia. Obesity is the second leading contributor to Australia's burden of disease due to its complications, which include cardiovascular disease, type 2 diabetes, chronic kidney disease, fatty liver, obstructive sleep apnoea, and several cancers.

Many of these complications can be prevented or mitigated with a loss of as little as 5% of total body weight, with greater weight loss usually resulting in progressive improvements in obesity‐related complications and quality of life.

This MJA narrative review shares more.

Learning Outcomes

1. Explain key components of the article
2. List main findings
3. Recognise the long-term approach of type-2 diabetes medicines in sustaining the health benefits of patients.

Details

Author: Rosalind Walmsley and Priya Sumithran

Article Type: Narrative Review